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Maintenance of progenitor cell properties in development is required for proper organogenesis of most organs, including those derived from the
endoderm. FGF10 has been shown to play a role in both lung and pancreatic development. Here we find that FGF10 signaling controls stomach
progenitor maintenance, morphogenesis and cellular differentiation. Through a characterization of the initiation of terminal differentiation of the
three major gastric regions in the mouse, forestomach, corpus and antrum, we first describe the existence of a “secondary transition” event
occurring in mouse stomach between E15.5 and E16.5. This includes the formation of terminally differentiated squamous cells, parietal, chief and
gastric endocrine cells from a pre-patterned gastric progenitor epithelium. Expression analysis of both FGF and Notch signaling components
suggested a role of these networks in such progenitors, which was tested through ectopically expressing FGF10 in the developing posterior
stomach. These data provide evidence that gastric gland specification and progenitor cell maintenance is controlled by FGF10. The glandular
proliferative niche was disrupted in pPDX-FGF10FLAG mice leading to aberrant gland formation, and endocrine and parietal cell differentiation
was attenuated. These effects were paralleled by changes in Hes1, Shh and Wnt6 expression, suggesting that FGF10 acts in concert with multiple
morphogenetic signaling systems during gastric development.
© 2006 Elsevier Inc. All rights reserved.Keywords: Endoderm; Stomach; FGF10; FGFR2; Notch; Hes1; Differentiation; Sox2; Chief cells; Parietal cells; SPEMIntroduction
Development of the mammalian gut is a highly orchestrated
process involving a multitude of morphogenetic processes,
tissue interactions and cell differentiation events. Of the tissues
derived from the gut endoderm, development of the budding
organs such as the lung, liver and pancreas is best characterized,
and several gene products and signaling systems have been
described securing regional identity and morphogenetic devel-
opment of these organs (Bellusci et al., 1997; Costa et al., 2001;
Jensen, 2004; Lemaigre and Zaret, 2004). In contrast, the
morphogenesis of the main gut tract, composed of esophagus,
stomach and intestinal system, is less well characterized, and
most studies related to cell differentiation within these regions
have focused on the behavior of the gut endoderm in the normal
adult, or transformed state, through investigations of stomach
and intestinal cancer.⁎ Corresponding author. Fax: +1 303 315 4892.
E-mail address: jan.jensen@uchsc.edu (J. Jensen).
0012-1606/$ - see front matter © 2006 Elsevier Inc. All rights reserved.
doi:10.1016/j.ydbio.2006.11.017Gastric mesenchyme is essential for survival of the
epithelium in vitro, and tissue-grafting experiments have
shown that a diffusible factor from the mesenchyme is critical
for stomach epithelial development in the chicken (Koike and
Yasugi, 1999). Recombination with forestomach mesenchyme
did not change the fate of glandular epithelium and vice versa
after E11.5 in the mouse (Fukamachi et al., 1979), suggesting
that the primary specification of the gastric epithelium occurs
before E11.5. Factors that influence this primary specification
include the mesenchymal-expressed Hoxa5 (Aubin et al., 2002)
and Barx1, a homeobox gene that act upstream of Wnt
antagonists (Kim et al., 2005). In addition to this primary
specification of the stomach, a secondary cell specification and
glandular formation is required to form the mature stomach.
Differentiation of specific cell lineages and invaginations of
epithelium to form glands begins already in the embryo, but
mature glands are not formed until after birth. Sonic hedgehog
expressed in the epithelium has been shown to regulate gland
development in the adult mouse stomach (van den Brink et al.,
2001), and BMP (Narita et al., 2000) and Notch signaling
(Matsuda et al., 2005) is critical for gland formation in the
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identity of any mesenchymal expressed morphogen(s) being
responsible for regulating epithelial cell differentiation in the
embryonic stomach.
Several studies have revealed significant sharing of gene
function along the gut. We and others previously showed that
the Notch signaling system, via Hes1, acts as a unified
regulatory mechanism controlling the development of endoder-
mal endocrine cells in the lung (Ito et al., 2000), stomach
(Jensen et al., 2000), pancreas (Jensen et al., 2000), small
intestine (Jensen et al., 2000; Milano et al., 2004; van Es et al.,
2005) and colon (Jensen et al., 2000). Furthermore, this
signaling system might be critical for proper differentiation
from several, if not all, of the endodermal stem cell populations
in the gut throughout life (van Es et al., 2005; Milano et al.,
2004; Zecchini et al., 2005; Collins et al., 2004; Apelqvist et al.,
1999). Also, Ngn3 has been shown to be necessary for
endocrine development in both the pancreas (Gradwohl et al.,
2000), intestine (Jenny et al., 2002) and stomach (Jenny et al.,
2002; Lee et al., 2002).
We and others recently described the effects of over-
expressing the FGFR2-IIIb ligand FGF10 in pancreatic
epithelium (Norgaard et al., 2003; Hart et al., 2003). FGF10
is normally expressed by the distal-most pancreatic mesen-
chyme, and this mesenchymal/epithelial signaling is critical
for pancreatic epithelial growth (Bhushan et al., 2001).
However, FGF10 also plays a role in coordinating epithelial-
derived cell differentiation, as increased FGF10 signaling
leads to an almost complete abrogation of all differentiated
pancreatic cell types: endocrine, exocrine and ductal (Nor-
gaard et al., 2003; Hart et al., 2003). As this effect is
comparable to that observed during increased Notch signaling
(Hald et al., 2003; Murtaugh et al., 2003) and given that
pancreatic expression of notch signaling components was
increased in the pPDX-FGF10 mouse (Norgaard et al., 2003),
it is plausible that FGF10 may exert control of differentiation
via the Notch pathway. The requirement of Notch signaling in
FGF10-mediated suppression of pancreatic differentiation was
recently demonstrated by Miralles et al. (2006) using an
explant culture model.
In the present study, we questioned if such a genetic link
would be conserved in stomach development. We first define
the temporal onset of the gastric secondary transition and
demonstrate the spatial expression of FGF10/FGFR2 and Notch
components at this time. These results suggest a role in
mesenchymal-to-epithelial signaling of the FGF10/FGFR2
functional pair and a role of downstream Notch signaling in
epithelial progenitor maintenance. Taking advantage of the
expansion of the Pdx1 promoter domain into the stomach and
duodenal regions, we have here analyzed the specific effects on
stomach development in the presence of increased levels of
FGF10 signaling as provided by Pdx1-FGF10 transgenic mice.
We find that the stomach endodermal regions behave with an
overall similar mechanism to the pancreatic epithelium in that
cell differentiation is suppressed, although with selective effects
on specific cell lineages. Consequently, stomach morphological
development is severely disrupted. We also conclude thatsimilar to the pancreas, FGF10 induces expression of the Notch
target gene Hes1, indicating a conserved regulatory network.
Materials and methods
Transgenic mouse derivation and embryo isolation
FVB mice with transient ectopic expression of FGF10 controlled by the
Pdx1 promoter were generated as described in Norgaard et al. (2003) by oocyte
injection of a pPdx1-FGF10FLAG fragment. Date of transfer was set at E0.5 and
the embryonic gut was harvested in ice-cold PBS under stereomicroscope at day
E12.5, E14.5 or E18.5 for tissue or RNA. Genotyping was performed by PCR
using primers specific for the transgenic construct (Supplementary Table 1). A
total of n=3 E12.5 transgenic (TG) embryos, n=3 E14.5 TG embryos and n=6
E18.5 TG embryos were analyzed in this study. Non-transgenic littermates (WT)
were used as controls throughout.
Histology
Tissues were fixed in 4% PFA o.n., transferred to 30% glucose for 2 h and
15% sucrose in 50% OCT for 1 h followed by 1 h of 100% OCT before being
quick frozen in OCT. Immunohistochemistry was performed on 6 μm frozen
slides. Slides were dried at 37C, microwaved for 2×5 min in citrate buffer pH 6
and washed in PBS. Slides were then treated with 3% hydrogen peroxide for
5 min, washed in PBS and blocked with TSA blocking buffer (Perkin Elmer) for
1 h. Primary antibodies were applied o.n. The next morning, slides were washed
in PBS and incubated with either appropriate secondary antibody conjugated to
Texas red/Cy2/AMCA (Jackson ImmunoResearch) for 1 h or biotinylated
secondary antibody from Zymed (Histostain) for 30 min. After washes in PBS,
slides incubated with biotinylated secondary antibody were incubated with
streptavidin peroxidase conjugate (Zymed) for 15 min, washed in PBS and
incubated with 1:50 FITC-conjugated tyramide signal amplification (TSA)
reagent (Perkin Elmer) for 10 min. All slides were mounted in 30% glycerol in
PBS.
Primary antibodies and dilutions used in this study includes goat α-FGF10,
1:200, Abcam, USA; mouse HRP-conjugated α-FLAG, M2, 1:1000 (TSA),
Sigma, MO, USA; rabbit α-IDX1 (PDX1), Dr. Joel Habener, Boston, MA, USA,
1:2000; rat α-E-cadherin, ECCD2, 1:200, Zymed, CA, USA; rabbit α-β-catenin
Ab-1, 1:100, Neomarkers/Labvision, CA, USA; mouse α-human smooth
muscle actin, clone1A4, 1:500, DAKO, Denmark; rabbit α-chromogranin A,
18-0094, 1:200, Zymed, CA, USA; sheep α-human Pepsinogen II, K90132S,
1:200, Biodesign, ME, USA; rabbit α-H,K-ATPase α-unit (C terminal),
AB1674, 1:100, Chemicon, USA; rabbit α-secretin, H-067-04, 1:300, Phoenix,
CA, USA; mouse-α-glucagon, K79BB10, 1:200 Sigma, St. Louis, MO; rabbit-
α-somatostatin, 1:100, DAKO, Denmark; goat-α-ghrelin, sc-10368, 1:1000,
Santa Cruz Biotech, CA, USA; rabbit-α-CCK, 1:200, Immunostar, USA; rabbit-
α-gastrin 1:200, Neomarkers-Labvision, CA, USA; rabbit α-p-Histone-H3, 06-
570, 1:100, Upstate, VA, USA; rabbit α-PCNA, FL-261, 1:150, Santa Cruz
Biotech., CA, USA; rabbit α-Bek/FGFR2 (C17, recognizes both splice forms),
1:800 (TSA), Santa Cruz Biotech., CA, USA; rabbit α-Hes1 (Lee et al., 2005),
1:500 (TSA); rabbit-α-Sox2, 1:800 (TSA), Abcam, USA; Nkx-6.1, 1:500
(Jensen et al., 1996), Denmark; Rhodamine-Dolichos Biflorus Agglutin (DBA),
1:200, Vector Laboratories, CA, USA ; Fluorescein-Ulex Euopaeus Agglutin I
(UEA), 1:200, Vector Laboratories, CA, USA. Nuclei were stained for 5 min
with 1:2000 Hoechst where needed for morphometric studies.
In situ hybridization was performed on 6 μm frozen slides using
digoxigenin-labeled RNA probes. The RNA probes were generated by in
vitro transcription from linearized template DNA as described in (Norgaard et
al., 2003). DNA templates were derived from the following clones: FGF10 in
pCR4 (own); Hes1 in pBS-SKII (Dr. R. Kageyama, Uni. Kyoto, Japan); Notch1
in pBK-CMV (Dr. J. Hald, Denmark); Notch2 in pBK-CMV (Dr. J. Hald,
Denmark ); Jagged1 in pCR4 (own); Jagged2 in pSKII (Dr. G. Weinmaster,
UCLA); CDX2 in pT7T3D-pac (IMAGE clone 437757, Invitrogen); IFABP in
bluntII-topo (Dr. L. Sussel, UCHSC, USA); TFF2 in pSPORT1 (IMAGE clone
6431145, Open Biosystems); Wnt6 in pCMV-SPORT6 (IMAGE clone
6511061, Open Biosystems); Shh in Bluescript II-SK (Dr. A.P. McMahon,
Harvard, USA).
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(Roche) as previously described (Norgaard et al., 2003) followed by NBT-BCIP
substrate color reaction (Roche).
Slides were analyzed using an Olympus BX51 microscope station equipped
with Nomarski interference and images where obtained through a Pixera CL600
camera. At least 3 E12.5, 3 E14.5 and 3 E18.5 TG embryos from different litters
were characterized by histology. Three WT littermates were included per time
point for pair wise comparisons. The transgenic phenotypes of the three
replicates were similar although not identical.
Morphometry
Morphometric analysis was done using ImagePro v. 4.5 (Media Cybernetics)
software. Digital images were saved from 5 to 10 non-overlapping FOVs at 10×
or 20× for each slide, and at least 3 slides distributed across the stomach were
counted for each animal. Epithelial area was quantified by area integration based
on E-cadherin staining. For mean epithelial area per slide, the following number
of slides distributed across the stomach were measured: E18.5: 4 slides/80 total
stomach slides, E14.5: 3 slides/35 total, E12.5: 3 slides/15 total. Cell numbers
were counted automatically based on Hoechst staining, where a limited
watershed algorithm was applied to separate overlapping nuclei. Specialized cell
types were counted manually.
Multiplex RT-PCR
RNA was isolated from the stomachs of each of two transgenic E18.5
embryos from different litters and two littermate WT controls. A time series of
RNA from E14.5 to E18.5 stomachs was isolated from CD1 embryos by careful
dissection of the stomach into glandular stomach and forestomach. Stomachs
from 4 embryos were pooled for E14.5 samples, 3 embryos were pooled for
E15.5 samples and 2 embryos were pooled for each of the samples at E16.5,
E17.5 and E18.5. Tissue was homogenized immediately in TriZol reagent
(Invitrogen), and RNA was isolated according to manufacturers' protocol.
cDNA was synthesized from 2 μg RNA in a 50-μl reaction with 7 μg random
primer (Invitrogen), 40 μM dNTPs, 1× Promega opti buffer, 0.1 M DTT, 40 U
RNAsin (Fisher) and 200 U M-MLV RT enzyme (Fisher) at 37C for 60 min.
Semi-quantitative multiplex RT-PCR analysis was done essentially as
described in Jensen et al. (1996). PCR reactions with approximately 0.05 μg
cDNA in a 22-μl reaction with 10× buffer including MgCl (Promega), 8 mM
dATP, dGTP and dTTP, 4 mM dCTP, 20 μM of each primer (up to 6 primers in
each reaction), 0.5 U Taq polymerase (Promega) and 4 mM α-32P-dCTP were
run for 19 or 24 cycles depending on target abundance. The reactions were
analyzed by polyacrylamide gel electrophoresis, and the intensity of the
individual bands was quantified using ImageQuant software version 6.0
(Molecular Dynamics). All values are expressed as mean±SEM relative to the
internal standard. Primers were designed according to GenBank reports and the
sizes of the amplicons were 150–300 bp. Primer sequences are included in
Supplementary Table 1.Results
A secondary transition of the murine stomach occurs at
E15.5–E16.5
The murine stomach develops from a homogenous pseudo-
stratified epithelium but differentiates into several different
regions. At E17.5 the stomach consists of a forestomach region
with squamous epithelium and a glandular region with
stratified epithelium. These two regions can be easily
distinguished from the exterior morphology of the stomach
(Fig. 1A). The glandular stomach can be further divided into
the corpus and the antrum based on differentiated cell lineages.
In order to determine the exact onset of terminal cell
differentiation in the developing glandular stomach, weperformed multiplex RT-PCR for markers of differentiated
stomach cell lineages. Analyzing for expression of maturing
endocrine cells (chromogranin A), zymogenic chief cells
(pepsinogen C), parietal cells (H+/K+-ATPase) and pre-pit
cells (trefoil factor 1 and 2), we found complete absence of
expression at embryonic day 14.5, whereas all are highly
expressed at E16.5 (Fig. 1C). The pan-endocrine marker
chromogranin A is present at low levels at E15.5 but
expression doubles on E16.5 and remains constant for the
remainder of embryonic development. The parietal cell marker
H+/K+-ATPase is likewise undetectable until E16.5, peaking at
E17.5. Pepsinogen expressed by the zymogenic chief cell is
weakly detectable at E15.5 but increases dramatically on
E16.5. Finally, trefoil factor (TFF) 1 is strongly expressed from
E16.5 onwards, while TFF2 is weakly expressed at E15.5,
increases dramatically on E16.5 and remains more or less
constant during embryonic development. These results were
confirmed by immunohistochemistry for Pepsinogen C, H+/
K+-ATPase and chromogranin A (Figs. 1B and D). All three
markers were completely absent in E15.5 stomach, while
abundant positive cells were found in E16.5 stomach. The A-P
patterning into forestomach, corpus and antrum is already
evident at the histological level at this age as a region-specific
distribution of the three cell types was apparent: Chromogranin
A-positive endocrine cells were distributed throughout the
stomach glandular epithelium, Pepsinogen C-positive zymo-
genic cells were only present in the antrum, while H+/K+-
ATPase-positive parietal cells were only found in the corpus
(Figs. 1B and D). Only one immature gland noticed in this
study in the corpus-antrum transition region contained both
pepsinogen and H+/K+-ATPase-positive cells (Fig. 1D inset).
We note that for both antrum and corpus, morphogenetic
development of the gastric pit-gland unit is only rudimentary
at E15.5–E16.5, with shallow epithelial invaginations (Figs.
1B and D). Consequently, gastric cytodifferentiation is
initially independent of a complete pit-gland unit morpho-
genesis. In contrast to the glandular regions, the mouse
forestomach appears to generate only a single differentiated
cell type, easily distinguishable through the presence of a
stratified squamous epithelium, not found elsewhere in the
stomach. Inspecting the developmental profile of the mouse
forestomach between E14.5 and E18.5, we conclude that
squamous cell development occurs concomitantly with onset
of terminal differentiation in the glandular regions, between
E15.5 and E16.5, as the forestomach epithelium changes from
pseudostratified to squamous during this time (data not
shown). Thus, the stomach epithelium goes through a
secondary transition in a temporally and spatially coordinated
fashion in the mouse.
FGF10 and FGFR2 are expressed complementarily in the
gastric mesenchyme and epithelium during embryonic
development
The temporal and spatial specificity of cell differentiation in
the stomach suggests that cell differentiation is tightly regulated
here. Given the role of FGF10 in pancreatic progenitor
Fig. 1. The secondary transition of the stomach. (A) Regions of the stomach at E17.5. G.C: greater curvature, L.C. lesser curvature. (B) Co-staining of H+/K+-ATPase
(green), Pepsinogen C (blue) and E-cadherin in E16.5 stomach. The numbers refer to pictures in panel D). (C) Multiplex RT-PCR of expression of chromogranin A
(Chrg A), H+/K+-ATPase (Atp4b), pepsinogen C (Pgc) and Trefoil Factor 1 and 2 (Tff1 and Tff2). α-Tubulin (α-tub) was used as an internal control. The shown bands
are representative examples from two experiments. Ages analyzed included E14.5, E15.5, E16.5 E17.5 and E18.5 (n=2/gestational time point). (D)
Immunohistochemistry for H+/K+-ATPase and pepsinogen C or chromogranin A co-stained with E-cadherin at E15.5 (top row) and E16.5 (bottom row). Numbers refer
to positions in panel B). Insert 2 shows one forming gland with both pepsinogen and H+/K+-ATPase expressing cells. This was the only one found (n=3).
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role in regulating the secondary transition of the stomach as
well. First, we identified members of the FGF family expressed
during the late embryonic development of the stomach (E14.5–
E18.5) using a multiplex RT-PCR screen of all known FGF
family genes in the mouse (FGF1 to FGF23). Here we find that
FGF1-3, FGF7, FGF9 and FGF10 were expressed at or above
20% of our control gene, TATA box binding protein (TBP), at
one data point (Fig. 2A), but FGF10 was the only FGF
expressed at high levels before the secondary transition. In situ
hybridization for FGF10 confirmed the multiplex analysis and
showed the confinement of FGF10 expression to the gastric
mesoderm with strongest expression posterior (Fig. 3A, and
Supplementary Figs. 1A and 2). FGF10 is an FGFR2-IIIb
ligand and was previously found to be expressed in the pre-
differentiated mouse stomach at E11.5 well before cytodiffer-
entiation (Bhushan et al., 2001). Fgfr2-IIIb mRNA was
expressed at a constant level throughout the stages analyzed,
except for E14.5 expression that was higher in glandular regions
(where the Fgfr2-IIIb/TBP volume ratio of 2.5 compared to
ratios of 1–1.7, Fig. 2B). Using an antibody that detects both
splice forms, we found expression of FGFR2 protein in the pre-
forestomach and pre-antrum epithelium at E15.5 (Fig. 4A).
Only negligible staining could be discerned in the mesenchymeor in the epithelium of the pre-corpus region. Expression data
based on in situ hybridization at E14.5 showed epithelial
localization of Fgfr2IIIb mRNA, as well as Fgfr3 and Fgfr4
(Supplementary Fig. 1B), confirming the immunohistochemical
analysis and establishing that the FGFR2IIb isoform is
expressed here. At E18.5 FGFR2 protein expression in the
forestomach epithelium was confined to the basal stem cell
layer. Expression of FGFR2 had moved into the corpus region
where it localized to the forming glands, and expression was
persisting in the antrum, with strongest expression in the
forming glands (Fig. 4B). The region-specific expression of
FGFR2 makes it likely that FGF signaling is involved in spatial
patterning as well as temporal regulation of stomach develop-
ment. In order to validate the gastric patterning of FGFR2, we
used the gastric HMG box containing transcription factor Sox2,
as this is only expressed within the anterior-most endoderm with
a posterior boundary at the pyloric sphincter (Tsukamoto et al.,
2004). Immunohistochemistry for Sox2 on a consecutive slide
confirmed the gastric identity of the FGFR2 expressing
epithelium. Also, Sox2 expression was reduced in the corpus
mirroring FGFR2 expression (Fig. 4A). We conclude that
similar to the pancreas and lung, the FGF10/FGFR2 pair is
expressed in the stomach in a manner consistent with
mesenchymal-to-epithelial signaling.
Fig. 2. Cell signaling during normal stomach development. (A) Semi-
quantitative multiplex RT-PCR of the expression of FGFs in the glandular
stomach. Y-axis shows quantification of intensity of FGF-x bands relative to
TBP±SEM. (n=3). (B) Semi-quantitative multiplex RT-PCR of the expression
of Fgf10, the FGF10 receptor FgfR2b, the Notch signaling components Hes1,
Hes3, Notch1, Delta and Jagged2 as well as the gastric transcription factor
Sox2. The shown bands are representative examples from n=2 experiments
with exception of Fgf10 and FgfR2b RT-PCR that was performed four times.
Tbp was used as internal control.
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stomach
Notch signaling is downstream of FGF signaling in the
embryonic pancreas (Norgaard et al., 2003) and has been shown
to control gastric enteroendocrine development, through
activation of the bHLH factor Hes1. Expression of Notch
signaling components have been addressed during chicken
stomach development, where both cNotch1 and cNotch2,
cHairy 1 (orthologous to Hes1) and cHairy2 (orthologous to
Hes2) are predominantly confined to the epithelial compartment
(Matsuda et al., 2005). Mouse embryonic stomach has not been
similarly analyzed, although RT-PCR analysis of Hes1, Hes3,
Notch1, Jagged1 and Jagged2 has demonstrated their expres-
sion in the embryonic mouse stomach at E18.5 (Jensen et al.,
2000). We here demonstrate expression of Hes1 mRNA in the
embryonic stomach throughout development (Fig. 2B) and
confinement of Hes1 mRNA to the embryonic gastric
epithelium at E18.5 (Fig. 3B). We also find that abundant
expression of the transcriptional regulator Hes3 occur through-
out stomach development (Fig. 2B) and that Notch1 is
expressed in the embryonic stomach epithelial progenitors in
the mouse (Figs. 2B and 3B). Given that Norgaard et al. (2003)suggested a role for Jagged-type ligands during FGF10
stimulated notch signaling in the pancreas, we were particularly
interested in the spatial pattern of Jagged1 and Jagged2
expression. Jagged1 was not expressed by stomach epithelium,
but instead confined to vessels (Fig. 3B). In contrast, Jagged2
was expressed in a completely overlapping manner with
Notch1/Hes1 in the gastric epithelium in antrum and corpus,
and basal population of the forestomach epithelium (Figs. 2B
and 3B).
Generation of pPdx1-FGF10FLAG transgenic mice
To address the functional role of FGF10 signaling in gastric
development, we generated transient transgenic embryos
through injection of the full length, C-terminally FLAG-tagged
FGF10 coding region under control of 4.5 kb upstream Pdx1
proximal promoter (Norgaard et al., 2003; Stoffers et al., 1999;
Apelqvist et al., 1997; Li and Edlund, 2001) (Fig. 5A). The
Pdx1 promoter is abundantly expressed in the dorsal part of the
primitive gut from E8.5 (Ohlsson et al., 1993) and at lower
levels in the distal foregut region, including the posterior
stomach and duodenum E10 and onwards (Madsen et al., 2001;
Miller et al., 1994). Importantly, this non-pancreatic expression
is functionally relevant, as a hypermorphic allelic series of Pdx1
promoter mutants gradually deleting Pdx1 activity provided
evidence of a role of Pdx1 in both pyloric gland and Brunner
gland formation (Fujitani et al., 2006). The pPdx1-FGF10Flag
construct used here was previously shown to disrupt pancreatic
morphogenesis by blocking terminal differentiation of all
pancreatic cell types (Norgaard et al., 2003). Previous studies
of the exogenous Pdx1 promoter (using a 4.5-kb promoter
fragment activity) have revealed expression in posterior
stomach and duodenal endoderm, in addition to the pancreas.
We confirmed the expression of endogenous Pdx1 in the
anterior duodenal epithelium and posterior stomach epithelium
at E12.5, E14.5 and E18.5 (Fig. 5C), which was mimicked by
the 4.5-kb Pdx1 promoter used here (Fig. 6 and data not shown).
We analyzed expression of the FGF10FLAG transgene by virtue
of the FLAG-tag present as well as by ectopic expression of
FGF10 protein and mRNA. At E12.5 FGF10 was only
expressed in a few cells in the most posterior regions of the
stomach epithelium (Fig. 6A), corresponding with a very
limited PDX1 domain here (Fig. 5C). No expression was found
in Wt littermates. In E14.5 TG stomach, a much stronger
expression of FGF10FLAG protein was found (Fig. 6B) in
stomach epithelial cells. Similar to the pancreas, strongest
staining was observed in the plasma membrane rather than in
the cytoplasm. No FLAG or FGF10 staining was observed in
WT stomach (data not shown), and no FLAG staining was
observed in TG stomach mesenchyme (Fig. 6B). Compared to
E14.5, reduced expression was observed in E18.5 stomach—a
time point where expression of FGF10FLAG persists in pancreas
(Fig. 6C). We performed in situ hybridization for fgf10, which
revealed transgenic expression in a few antral epithelial cells at
E12.5 (Fig. 6A). In contrast, in situ hybridization revealed a
strong expression at E14.5, overlapping with Fgf10 and FLAG
staining (Fig. 6B). At E18.5 the fgf10 mRNA level was
Fig. 3. Notch components in stomach development. (A) In situ hybridization for
FGF10 shows mesenchymal expression in an E15.5 stomach. (B) In situ
hybridization for Hes1, Notch1, Notch2, Jagged1 and Jagged2 in forestomach
and fundus of E18.5 stomach.
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(Fig. 6C). No positive epithelial cells were found in WT
littermates. Corroborating the histological results, RT-PCR
revealed the presence of exogenous FGF10-Flag mRNA in
transgenic stomach at E18.5 (Fig. 6D). Given the transient
transgenic nature of the embryo generation process, individual
TG embryos represent individual lines and therefore displayed
degrees of variation of phenotype penetrance; the twotransgenic embryos analyzed by RT-PCR were from indepen-
dent litters and differed considerably in the amount of FGF10-
Flag mRNA expressed. We accredit this to mosaicism, TG
integration site, copy number insertion or a mix thereof.
Notwithstanding, all TG embryos analyzed displayed similar
alterations of stomach development.
Disrupted stomach morphogenesis in pPdx1-FGF10FLAG mice
Visual inspection of E12.5 TG embryos (n=3) revealed
minor disruptions of stomach morphogenesis. In contrast, at
E14.5 (n=3), we detected a major disruption of normal stomach
morphogenesis. The size of the stomach appeared slightly
reduced, and the ventricular lumen of the stomach appeared
filled with tissue. Furthermore, we could not identify the
presence of a pyloric sphincter, leaving the attachment zone of
the pancreas to the gastrointestinal tract undecided. We first
performed a histological analysis of the developing stomach
using markers of the epithelium (β-catenin) and the developing
circular and longitudinal muscles (smooth muscle actin) (Fig.
7A). In the normal E14.5 stomach, the ventricular space is lined
by a homogeneous pseudo-stratified epithelium, with little
folding. At a fixed radial distance, smooth muscle (SM) cells
differentiate, aligning accordingly to the future position of the
contractile muscles of the muscularis (Fig. 7A). In transgenic
littermates, almost the entire luminal area was populated by an
increasingly folded endodermal epithelium. SM cell differen-
tiation occurred at a similar radial distance to the hyperplastic
epithelium, properly following the epithelial folding pattern,
suggesting that the irregular muscle condensation is secondary
to the morphogenesis of the epithelium (Fig. 7A). Consequent-
ly, we interpret these data to signify that the epithelial/
mesenchymal signaling regulating SM differentiation is not
disturbed. At E18.5 the phenotype was even more striking, with
excess folding of the epithelium in the corpus and antral
regions, which branched into complex tree-like structures never
observed in the WT littermates (Figs. 7A and B and
Supplementary Figs. 3 and 4). The forestomach region
developed a stratified squamous epithelium indistinguishable
from the WT forestomach region, although in some regions we
noted a disturbed differentiation process, which included failure
in development of the stratified epithelium (Supplementary
Figs. 3 and 4C–D). In those regions, we also observed that the
normal confinement of DNA-incorporating nuclei to the basal
cells seen in WT was disrupted (Supplementary Figs. 4E–F).
The smooth muscle development appeared normal in the
forestomach.
Conservation of distal foregut patterning in pPdx1-FGF10FLAG
mice
Due to the difficulty in defining the stomach/duodenal
junction morphologically in both E14.5 and E18.5 transgenic
embryos, we decided to investigate whether this region had
been properly specified using a combination of stomach,
pancreatic and intestine-specific markers. Using the region-
specific lectins DBA and UEA which marks the prospective
Fig. 4. FGFR2 distribution in the stomach. (A) Immunostaining for FGFR2 and Sox2 in E15.5 stomach FGFR2 is expressed in the epithelium in the pre-forestomach
and pre-antrum regions at E15.5. Arrow points to the esophagus. The Sox2 antibody displays a specific nuclear staining in the gastric epithelium and a nonspecific
cytoplasmic staining in mesenchymal cells. (B) Immunostaining for FGFR2 in E18.5 stomach. FGFR2 is expressed in the basal layer of the forestomach epithelium,
the forming glands in the corpus and in all epithelial cells in the antrum at E18.5. Picture showing antrum is rotated 90° left and has an insert showing a lower
magnification of the same region (not rotated). Nuclei are stained with Hoechst.
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able to define the attachment zone of the Nkx6.1-expressing
hyperplastic pancreas cells within the prospective duodenal
region (Figs. 8A–D), as it normally occurs. However, the
regionalization of the pancreas/duodenum connection was not
strict as Nkx6.1-expressing pancreatic cells were clearly
observed within the duodenal area at E14.5. Given the
complete absence of a main pancreatic duct, and the absence
of the normal narrowing of the evaginating pancreatic
epithelium, this is not surprising. We noted that UEA-positive
gastric cells were clearly observed in a more anterior location
than the pancreatic/duodenal zone, indicating the conservation
of the distal foregut patterning in the FGF10 transgenic
embryo. It therefore seems that the distal foregut patterning
mechanisms operate even in the absence of a pyloric sphincter
and a normal pancreas. These results were corroborated at
E18.5, where both pancreatic evaginations, dorsally and
ventrally, entered the adjacent endoderm at the level of the
Cdx2-expressing duodenum (Fig. 8E).
Proliferation analysis of stomach epithelial cells
The increased folding of the epithelium might be suggestive
of an increased cellular proliferative rate, or a result of FGF10-
mediated morphogenetic effects upon branch-point selection.
To analyze for total epithelia area changes, we measured gastric
glandular epithelial area at E12.5, E14.5 and E18.5. We also
compared cell proliferation and cell death rates within the
glandular region (antrum/corpus, forestomach excluded). Wedid not find any evidence suggesting an increase in total
epithelial area (Fig. 9B), nor did we find a reduction in cell
death using a combination of Hoechst and TUNEL staining, as
this parameter was negligible in the normal embryonic stomach
as well as in the TG stomach (data not shown). To account for
any change in the proliferative index, we analyzed for M-phase-
activity (using phosphorylated histone H3, pHH3), specifically
in the stomach epithelium by co-staining with E-cadherin.
Analysis of E12.5, E14.5 and E18.5 TG mice and WT
littermates did not reveal a significant increase in the
proliferative activity in stomach glandular epithelium (Fig.
9A). Also, the number of cells (counted as Hoechst nuclei) per
area was unchanged, signifying that cell size was not affected
by ectopic FGF10 (results not shown). We can therefore exclude
that the increased folding is caused by an overall increase in
epithelial area. Instead, it seems likely that FGF10 is
specifically promoting epithelial folding as a chemotaxic factor
similar to what is seen in the lung (Park et al., 1998). Therefore,
to elucidate whether FGF10 changes the pattern of proliferating
cells rather than the overall proliferative index, we analyzed the
distribution of cycling cells with PCNA staining. Cycling
PCNA-positive cells are confined to the glandular compartment
in normal E18.5 antrum epithelium but was distributed
throughout the luminal and glandular compartments in the TG
antrum (Fig. 9C). This disruption of the proliferative niche was
not absolute, as patches of PCNA-negative luminal cells were
found (Fig. 9C, upper right panel). To further pursue the effect
of FGF10 on luminal and glandular compartments, we next
analyzed the distribution of gland and luminal markers.
Fig. 5. (A) pPDX-FGF10-Flag construct. (B) Whole gut of E18.5 pPDX-
Fgf10FLAG embryo and wild-type littermate. The TG stomach is smaller and
appears denser. (C) Immunohistochemistry for PDX1 shows expression in
E12.5 most posterior stomach, and E14.5, pancreas, anterior duodenum and
posterior stomach including antrum and posterior corpus. PDX1 expression is
still present in E18.5 antrum.
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secretory cells
Pepsinogen C and H+/K+-ATPase is expressed by chief and
parietal cells respectively in the glands of the E18.5 stomach,
while Trefoil factor 1 (TFF1, formerly pS2) and Trefoil factor 2
(TFF2, formerly spasmolytic polypeptide, SP) are expressed by
mucus producing luminal cells (Otto and Patel, 1999).
Immunostaining for Pepsinogen C showed a 168% increase in
the number of chief cells (P<0.05) (Figs. 10B and C) and an
expansion of these cells to nodes of branching epithelium not
located within the mesenchyme (Fig. 10B). Interestingly,
immunostaining for the C terminal end of the H+,K+-ATPase
α-unit showed a 78% decrease in parietal cells (P<0.05). This
decrease was corroborated by multiplex RT-PCR. mRNA
expression of the mucin associated Trefoil Factor 2 was
unchanged (Fig. 10A), but in situ hybridization revealed a
shift in localization from luminal cells in the WT corpus to
glandular cells in the TG (Fig. 10B). It thus seems that the Tff2
expressing mucus cells form unperturbed by FGF10, but that
their localization has been shifted. Trefoil factor 1 expression
and localization were unchanged (Fig. 10A and data not
shown). In situ hybridization for intestinal fatty acid binding
protein (Ifabp), that is expressed in the stomach of Ngn3 nullmice (Lee et al., 2002) and in intestinal metaplasia of the
stomach, did not show any expression in the stomach of pPDX-
FGF10 mice (Fig. 10C and data not shown), and neither did the
intestinally expressed TFF3 (data not shown). The analysis of
exocrine cells showed that not only are the luminal and
glandular cell types displaced by FGF10, certain cell fates are
also suppressed while others are accelerated. Previously
published results show suppression of terminal endocrine cell
fates by FGF10 during ectopic expression in the pancreas
(Norgaard et al., 2003). We therefore continued to analyze
differentiation of endocrine cell types.
FGF10 attenuates stomach endocrine terminal differentiation
We described the onset of gastric endocrine differentiation at
E15.5–E16.5 using the pan-endocrine marker chromogranin A.
More specifically, the gastric endocrine cell complement
includes secretin, glucagon, somatostatin, ghrelin and gastrin
producing cells, predominantly. The majority of the endocrine
cells are formed based on the activity of bHLH components,
including the Ngn3 gene (Jenny et al., 2002; Jensen et al., 2000;
Lee et al., 2002), and are repressed by the Notch system, acting
through Hes1 (Jensen et al., 2000). We compared E18.5 WTand
TG littermates for effects on stomach cell differentiation by
semi-quantitative multiplex RT-PCR (Fig. 10A) and immuno-
histochemical evaluation of markers for differentiated stomach
cell types (Figs. 10B and C). Multiplex RT-PCR showed a
downregulation of mRNA for chromogranin A (with relative
ratios of Chgr.A/TBP of TG1: 0.07, TG2: 0.02, WT1: 0.21,
WT2: 0.24; Fig. 10A). This effect was most pronounced in the
TG embryo with the highest expression of ectopic FGF10.
Immunohistochemistry for chromogranin A-positive cells
likewise showed a significant reduction (81% reduced com-
pared to WT (P<0.05)). However, a few chromogranin A-
positive cells were still present and we went on to discern the
identity of those cells. Glucagon staining revealed an almost
complete loss of A cells (92% reduced compared to WT
(P<0.05)) and staining against secretin showed a significant
decrease in enterochromaffin cells (89% reduced compared to
WT (P<0.05)), while analyzing for somatostatin producing D
cells showed no significant change. This is a surprising result,
since a lack of somatostatin expression was reported in the
Ngn3−/− stomach (Lee et al., 2002). Quantitation of Grelin
cells did not reveal a statistically significant change, although
ghrelin cells were significantly reduced in two out of three
transgenic mice. Stomach gastrin expressing cells (G-cells)
where not detected at this time in development in WT or TG
embryos.
FGF10 leads to nuclear translocation of FGFR2
As shown by multiplex RT-PCR, mRNA for FGFR2b is
present in the embryonic stomach and based on immunohis-
tochemistry the protein is present in the cytoplasm/membrane
of the stomach epithelium at E14.5 and E18.5. Upon
expression of FGF10 in the TG mice the levels of
FGFR2b are unchanged (Fig. 12), but immunohistochemical
Fig. 6. Gastric expression of exogenous FGF10 mRNA and protein. (A) E12.5 posterior stomach. Expression of FGF10 was detected with an antibody that detects only
high levels of the protein. Fgf10 mRNAwas detected by in situ hybridization on an adjacent slide. A few cells in the most posterior stomach of the TG expressed
FGF10. No staining was detected in WT littermates. (B) E14.5 posterior stomach (lower epithelium). Flag and FGF10 protein detected by immunohistochemistry and
Fgf10mRNA detected by in situ hybridization. No staining was detected in WT littermates (data not shown) n=3. ISH and IHC were performed on consecutive slides.
(C) E18.5 antrum. Flag and FGF10 protein detected by immunohistochemistry and Fgf10 mRNA detected by in situ hybridization. No staining was detected in WT
littermates (data not shown) n=3. Fgf10mRNAwas only detected in glandular structures at this stage although the protein could also be detected in luminal cells. (D)
Semi-quantitative RT-PCR for the Fgf10-Flag construct in E18.5 stomach of two transgenic mice and their WT littermates. The shown bands are representative
examples from three experiments.
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cytoplasm/membrane to the nucleus in the forming glands
(Fig. 11B). This localization event was never detected in
stomach epithelium of wild-type littermates (Figs. 11B and
4A and B). Given the observed increase in pepsinogen-
expressing cells, we speculated whether nuclear localization
of FGFR2 was associated with chief cell differentiation. Co-
staining with pepsinogen and FGFR2 showed no co-
localization (Fig. 11B). In contrast, the widespread nuclear
presence of FGFR2 in E-cadherin expressing and terminal
marker negative stomach epithelial cells suggests that FGFR2
nuclear entry is a result of ongoing FGF10 signaling in the
arrested progenitors.
FGF10 induces Hes1 expression in embryonic stomach
We next analyzed expression of notch pathway components
in the pPdx-FGF10FLAG stomach by multiplex RT-PCR (Fig.
12). Hes1 expression is very low in wild-type mice, but it wasconsiderably increased in the TG mice, while levels of Jagged1
and 2 were unchanged (Fig. 12). Immunohistochemistry for
Hes1 using an antibody (Lee et al., 2005) that in our hands only
allows detection of high Hes1 levels showed upregulation of
Hes1 in the epithelium of the TG mouse (Fig. 11A). Hes1 was
detected in the forming glands in the antrum, consistent with the
area where we find the strongest expression of FGFR2 and
ectopic FGF10 at E18.5.
Effects of FGF10 on gastric morphogenetic signaling networks
Sonic Hedgehog (Shh) has been shown to be important for
stomach gland development in both chicken and mouse
(Fukuda et al., 2003; van den Brink et al., 2001) and is
downstream of FGFR2b in limb development (Revest et al.,
2001). Shh is expressed in gastric epithelium and has been
localized to parietal cells in human adult stomach and in
parietal and zymogenic cells in murine adult stomach (van
den Brink et al., 2001). Our expression analysis showed a 2-
Fig. 7. Disturbed gastric morphogenesis in Pdx1-FGF10 embryos. (A)
Immunohistochemistry for smooth muscle actin and the epithelial marker
beta-catenin. (B) Immunohistochemistry for E-cadherin on E18.5 TG and WT
stomach.
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also analyzed the expression of BMP4, as this mesenchymal
expressed signaling molecule has been shown to be a down-
stream target of Shh in mouse adult stomach (van den Brink et
al., 2001). No change in BMP4 expression was noted. Similarly,
BMP2 expressed by gastric mesenchymal cells (Kaestner et al.,
1997) was unaltered (Fig. 12). Wnt signaling is critical for
intestinal progenitor/stem cell maintenance, and multiple studies
indicate a role in both normal and transformed growth of gastric
cells (Perreault et al., 2005; Tsukamoto et al., 2003; Kim et al.,
2003). Wnt5A is highly expressed in the gastric and intestinal
mesenchyme (Lickert et al., 2001), but we did not observe any
changes in overall gastric expression in the Pdx1-FGF10
transgenic model. In contrast, Wnt6 is expressed in the normal
embryonic stomach, but wewere unable to detect any expression
ofWnt6 in transgenic stomach (Fig. 12). In situ hybridization for
Wnt6 in gastric development showed that Wnt6 is exclusively
expressed by the gastric epithelium (Supplementary Fig. 5). The
transcription factor Sox2 is expressed in gastric and esophageal
epithelium with a more anterior expression domain early in gut
development, which expands into the posterior stomach just
prior to the secondary transition (Fig. 4 and results not shown)
and is also one of a few transcription factors expressed inembryonic stem cells that is lost upon differentiation (Carlin et
al., 2006). Sox2 expression was lowered in the pPDX-FGF10
mouse in a manner correlating with levels of ectopic FGF10
(Fig. 12).
Discussion
Although the stomach is among the largest organs, relatively
little is known of its morphogenesis and development,
particularly in relation to which genetic networks may
coordinate the process of gastric cell differentiation. To better
characterize the temporal onset, and local patterning of gastric
cell differentiation, we employed staining techniques for the
terminal gastric products allowing the visualization of chief,
parietal, mucous and gastric endocrine cells, combined with an
RT-PCR procedure. We conclude that each of the three major
gastric regions – forestomach, corpus and antrum – initiates
terminal differentiation concomitantly at E15.5.
We define this strict temporal onset of terminal differenti-
ation as the “secondary transition”, reserving the temporal
specification of pro-gastric endodermal cells towards the gastric
fate at early somite stages as the “primary transition”—a
process involving early splanchnic mesoderm signaling con-
trolled by Hox-gene family patterning (Pitera et al., 1999;
Aubin et al., 2002) and the homeobox gene Barx1 (Kim et al.,
2005). No terminal differentiation events appear associated with
the gastric primary transition, in contrast to that of the pancreas.
The gastric secondary transition is characterized by the initial
presence of terminal cell types and coincides with the time when
the caudal gastric epithelium is first starting to form glandular
structures. At E15.5 the invagination of epithelium and
subsequent glandular formation is initiated but is far from
completed when the terminal cellular fates are induced (E16.5).
Thus, we can conclude that gastric cytodifferentiation during
the embryonic development operates irrespectively of the
presence of a mature gastric pit-gland unit.
In comparison to the pancreas, where the “pancreatic
secondary transition” occurs at E13.5–E14.5 and signifies the
development of mature exocrine, ductal and insulin-producing
cells, the stomach is 2 days delayed. This delay argues against
sharing of any systemic factors that might help trigger the
secondary transition in these adjacent organs. It is currently
believed that organ-intrinsic factors acting in mesenchymal-to-
epithelial signaling are the major determinants in orchestrating
the onset of the secondary transition in the pancreas. FGF10 is a
critical part in this and helps to maintain the undifferentiated
pancreatic progenitor state prior to the secondary transition, in
part through maintenance of Notch signaling (Norgaard et al.,
2003). These observations motivated us to address if FGF
signaling similarly guide stomach progenitor cell maintenance
and if this may be similarly involving the control of Notch
signaling. To address the identity of FGF family proteins
expressed in gastric development, we screened all members by
RT-PCR performed on a kinetic series of embryonic stomach
cDNA. These results highlighted FGF10 as a plausible FGF
family member playing a role prior to the secondary transition
in the stomach. FGF10 is expressed abundantly in the adjacent
Fig. 8. Distal foregut patterning. (A) Nkx6.1 immunostaining showing the
position of the pancreas at E14.5. (B) FITC-UEA staining at E14.5. (C) FITC-
UEA, Rhodamine-DBA and Hoechst staining merge. (D) Rhodamine-DBA
staining showing the position of the duodenum at E14.5. (E) Cdx2 in situ of the
duodenum at E18.5.
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mesenchymal cells in the posterior stomach (Fig. 3 and
Supplementary Figs. 1A and 2). It is thus positioned as a
component that might influence gastric epithelial cells, prior to
the secondary transition. The predominant receptor for FGF10,
FGFR2IIIb, was in turn expressed mainly in the gastric
epithelium, arguing for a mesenchymal/epithelial interaction,
similar to what is observed in lung and pancreas. We noted that
FGFR2 expression was also not uniform, as epithelium in the
corpus expressed only minor amounts of FGFR2 prior to the
secondary transition, which could indicate that corpus might
differentiate between FGF10 availability as compared to the
antrum. As FGF10 and FGFR2IIIb expression is maintained
after the secondary transition, FGF signaling appears to have a
later role in the more mature gastric epithelium as well. We find
expression of multiple Notch signaling components in gastric
progenitor cells. Notch1, Notch2, the downstream target Hes1
and the ligand Jagged2 are all expressed at high levels in the
stomach prior to the secondary transition. Following the
transition, expression can still be observed in the basal
population of the forestomach and in epithelial cells of the
antrum and corpus, but not in differentiated squamous cells. It is
thus likely that notch signaling also plays a role in murine
gastric development.In order to investigate the role of FGF10/FGFR2 signaling in
embryonic stomach, we forced epithelial expression of FGF10,
disrupting the FGF10 gradient from the mesenchyme. The
results provide evidence for a role of FGF10 in gastric gland
formation and progenitor maintenance and the resulting
suppression of differentiation bears some resemblance to that
observed during pancreatic development (Norgaard et al.,
2003).
The most apparent phenotypic disruption is a luminal
branching of the epithelium, contrasting with the folding into
the mesenchyme observed during gland formation in the normal
stomach. We show that this luminal branching is not due to an
increase in overall epithelial area or proliferation, but rather a
change from gland niche restricted to diffuse proliferation. This
phenotype reflects what has been seen in the lung, where
FGF10 regulates directional outgrowth as a chemoattractant,
but only acts as a modest proliferation factor (Park et al., 1998).
Very recently, two studies describing the gastric phenotype of
Fgf10−/−, Ffgr2IIb−/− mice (Spencer-Dene et al., 2006) and
virus-mediated overexpression of Fgf10 and a secreted FGFR2b
in chicken (Shin et al., 2006) observed a similar role of Fgf10 to
the one reported here in regulation of gland formation. Both
knockout mouse models show a decrease in the formation of
complex glands, as does the model of secreted FGFR2b in
chicken, while the virally mediated fgf10-overexpression model
shows hypermorphic epithelial structures similar to what we
report here. In contrast to our overexpression model, the
chicken study ascribes the role of Fgf10 in gland formation to a
direct regulation of cell proliferation. However, only a modest
increase in the percentage of proliferating cells upon over-
expression of fgf10 (Shin et al., 2006) is observed. This
difference may be due to species differences in regulation of
proliferation, also supported by the observation that the chicken
gastric epithelium at late stage 36/day 10 does not have a
defined proliferative zone (Shin et al., 2006). Also, the level of
Fgf10 expression in the chicken study likely exceeds that
obtained through the ectopic expression in the mouse, possibly
leading to the observed difference in mitogenic activity. This
argument would also help explain the difference in mitogenic
FGF10 signaling in the pancreas as compared to the stomach in
the pPDX-FGF10FLAG model; Activity of the Pdx1 promoter in
the pancreas is higher than in the gut (Fig. 5), and expression of
TG fgf10 protein is indeed lower in the stomach (this paper and
Norgaard et al., 2003). Thus, we believe it is entirely possible
that fgf10 operates both as a chemotaxic factor in gland
development at lower levels, and at higher levels through
induction of epithelial growth.
We hypothesized that the increased branching would
associate with exogenous gland formation, and indeed expres-
sion of the glandular marker pepsinogen C was increased and
chief cells had spread to branching nodes in the lumen. In
contrast, the parietal cell type was almost absent, while the
luminal marker TFF1 was preferentially expressed in forming
glandular structures, suggesting that luminal cells ectopically
differentiate in the glandular domain. This reversal of
localization of pepsinogen and TFF1 is similar to what is seen
in the chicken Fgf10 overexpression model (Shin et al., 2006).
Fig. 9. Analysis of cellular proliferation. (A) Proliferation of epithelial cells in the glandular stomach as detected by pHH3, E-cadherin and Hoechst co-staining is not
significantly altered by ectopic FGF10 at E12.5, E14.5 and E18.5 in the stomach (n=3 WT/TG embryos with each n=3 slides distributed across the stomach with no
more than 160 μm between slides analyzed at each time point). (B) Epithelial area per slide as measured by E-cadherin staining is unaltered by transgene expression at
E12.5, E14.5 and E18.5 (n=3 WT/TG embryos with each n=4 (E18.5) or n=3 slides distributed across the stomach with no more than 120 μm between slides
analyzed at each time point.) (C) PCNA immunostaining shows disruption of the proliferative nice in E18.5 antral stomach. PCNA is shown in green and E-cadherin in
red. The two PCNA stainings are from different embryos.
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parietal cell fate was repressed. Both cell types are glandular,
although chief cells are located deeper in the gland. We
speculate that early gastric A-P patterning might have been
affected. We show that at the initial time of their development, a
spatial separation of parietal and chief cells in the corpus and
antrum exist. Therefore, the observed loss of parietal cells and
gain of chief cells in the transgenic model would reflect that the
corpus acquires antral identity, as we also found no data to
support expansion of the antrum by increased proliferation. The
hypothesis that Fgf10 regulates AP-patterning is reinforced by
the fact that Shh, which is normally expressed mostly in the
anterior stomach (Aubin et al., 2002), is downregulated by
overexpression of FGF10 (this study) and upregulated in the
fgf10 knockout (Spencer-Dene et al., 2006). It is worthwhile to
note that for both the fgf10 and Fgfr2IIIb knockout mice a
reduced antral stomach epithelium is observed (Spencer-Dene
et al., 2006), consistent with a role of FGF signaling in
promoting antral regionalization. Interestingly, “antralization”
is observed in certain gastric metaplasias, also known as
“SPEM” (spasmolytic peptide expressing metaplasia), charac-
terized by oxyntic atrophy and a shift in localization of TFF2
mRNA from the mucous neck cells in the normal adult fundusto the lower two thirds of the glands in the H. felis-infected
fundus and in SPEM (Nomura et al., 2004; Wang et al., 1998),
similar to what we see. Obviously the two phenotypes cannot be
directly compared, as the embryonic stomach described here
does not posses the mature glands described in SPEM, but these
results nonetheless suggest that ectopic expression of FGF10 in
the embryonic stomach results in a SPEM-like embryonic
phenotype and consequently indicates a role of FGF signaling in
gastric metaplastic development (Schmidt et al., 1999). We
speculate that the normal gradient of FGF10 and FGFR2-
expression in the stomach may help specify antrum versus
corpus/fundus fate choices. The lower levels of FGF10 and
FGFR2 in corpus (this study and Aubin et al., 2002) suggest that
progenitors here normally experience lower FGFR2 signaling
as compared to antrum. In TG embryos, on the other hand, the
FGF10 availability is much increased, possibly reaching up to,
or above, normal antral levels, and presumably causing the
antralization of the corpus. Further experiments are needed to
validate if this gradient of FGF signaling helps specify stomach
region identity.
Similar to what is seen in the pancreas of pPDX1-FGF10FLAG
mice (Norgaard et al., 2003), we saw almost complete
elimination of endocrine cell fates. Taken together with the
Fig. 10. Analysis of Cell Differentiation. (A) Semi-quantitative multiplex RT-PCR of the differentiation markers Trefoil Factor 1 (Tff1), Trefoil Factor 2 (Tff2), H+/K+-
ATPase (Atp4b), chromogranin A (Chrg A) and pepsinogen C (Pgc). The shown bands are representative examples from two experiments. (B) Immunostainings of
chromogranin A with E-Cadherin, H+/K+-ATPase and pepsinogen and in situ hybridization of Tff2 in E18.5 pPDX-FGF10 and WT littermates (n=3). (C)
Quantification of immunostainings shown in panel B and immunostainings for somatostatin, secretin, glucagon and ghrelin. Positive cells per mm2 epithelium as
marked by E-cadherin was quantified on three slides distributed throughout the stomach for each of three different WTor TG mice and the mean calculated. Statistical
significance was tested using the Student's T-test. No Ifabp was detected in the stomach by in situ hybridization of either WT or TG.
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Fgf10 inhibits differentiation of the gastric progenitors towards
the majority of cell fates, thus maintaining the progenitor cells.
In the pancreas, this Fgf10 effect is mediated through Notch
signaling (Norgaard et al., 2003). When we analyzed down-
stream changes in transcription of notch signaling components,
we noted that Fgf10 elicits an upregulation of Hes1 expression;
supporting our hypothesis that Fgf signaling is upstream of
Notch signaling in the stomach. This does not seem to occur
through increased levels of jagged-ligand production, as we
previously suggested for the pancreas. It has previously been
shown that Hes1 regulates endocrine differentiation in the
murine stomach (Jensen et al., 2000), and active Notch signaling
inhibit terminal cell fates in the stomach of the chicken (Matsudaet al., 2005). Interestingly, activated Notch also promote
glandular specification in the chicken (Matsuda et al., 2005),
suggesting that not only the progenitor maintenance effect of
FGF10, but also the increased formation of glandular structures
seen, could be mediated through notch signaling. Further
research is needed to elucidate this aspect in the mouse.
Fgfr signaling affects several downstream signaling path-
ways, and so we also analyzed changes in alternative pathways.
An immediate molecular effect of ectopic expression of FGF10
was the occurrence of nuclear localization of FGFR2. The
biological relevance of nuclear localization of FGFR2 is
unknown, but in this case it seems to be a response to hyper-
stimulation of the receptor, as it was never observed in wild-
type stomach epithelium. However, nuclear localization of
Fig. 11. Changes in Hes expression and FGFR2 intracellular distribution. (A)
Immunohistochemistry of Hes1 and E-cadherin. (B) Immunohistochemistry of
FGFR2 and E-cadherin. Enlargement of area in the TG also shows pepsinogen
staining. Lu: towards the lumen of the stomach.
Fig. 12. Changes in cell signaling in the pPDX-FGF10 stomach. Semi-
quantitative multiplex RT-PCR of the expression of ectopic FGF10-Flag,
endogenous Fgf10, the notch targets Hes1, notch ligands Jagged1 and
Jagged2, Bmp2 and 4, Wnt5a and 6, Sox2, Sonic hedgehog (Shh) and the
FGF10 receptor FGFR2b. Tbp was used as control. The shown bands are
representative examples from two experiments.
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artifact of overexpression of ligand in all cases, as it has
previously been described in normal Sertoli cells, where it
disappears in FGF9 null mice (Schmahl et al., 2004). Nuclear
localization of FGFR2 also occurs in osteoblasts in association
with prostaglandin induction (Sabbieti et al., 2005) and thus
seems to have functional relevance. Interestingly, nuclear
FGFR1 acts as a transcriptional regulator that stimulates growth
and differentiation responses (reviewed in Stachowiak et al.,
2003), and nuclear FGFR2 has been associated with differen-
tiation of Sertoli cells (Schmahl et al., 2004). A direct
association with terminal differentiation in the gastric epithe-
lium is not evident, as nuclear FGFR2 did not co-localize with
pepsinogen in the pPdx1-FGF10 TG mice.
Stomach development and homeostasis has been shown to
be regulated in part by Wnt, Shh and BMP signaling and we
therefore analyzed whether ectopic FGF10 expression had any
influence on the transcription of components within these
pathways. Our data suggest negative effects of FGF10 on Wnt6
and Shh expression, but not on BMP2, BMP4 and Wnt5A. It
has previously been shown that Shh helps to induce BMP4
expression in adjacent submucosal cells of the hindgut in
chicken, but this induction was not found in midgut (Roberts et
al., 1995). Our results indicate that in the mouse, gastric BMP4
expression is likewise independent of Shh in the embryonic
stomach. We also analyzed the expression level of the
transcription factor Sox2, which is selectively expressed in
the stomach and esophagus regions of the endoderm, and found
a marked downregulation. This was surprising, given that Sox2
is induced in FGF-treated osteoblasts (Mansukhani et al., 2005),
but reinforces the hypothesis that Fgf10 regulates AP-patterning. It is noteworthy that Hes1, Wnt6, Shh and Sox2
all are expressed by gastric epithelium, whereas the BMP2, 4
and Wnt5a are mesenchymal. This supports the fact that we did
not see any changes in morphology of the mesenchyme and
shows that FGF10 ectopically expressed by epithelial cells
predominantly influences the epithelium itself.
We here provide evidence to support a role of FGF10 in
gland formation and gastric patterning, in addition to demon-
strating a functional role for FGF10 upstream of Hes1 in gastric
progenitor maintenance, extending the knowledge of FGF10 as
a mesenchymal-derived factor involved in epithelial cell
differentiation also to that of the stomach. FGF10-mediated
mesenchymal–epithelial signaling thus appears to be conserved
from anterior endoderm (lung) (Sekine et al., 1999), over distal
foregut (stomach and pancreas; Bhushan et al., 2001). The role
of FGF10 in more posterior regions of the gut needs to be
clarified, although data obtained in parallel with this study
indicate a similarly important role for FGF10 in duodenal
progenitor maintenance (will be described elsewhere). There-
fore, similar to the conserved nature of epithelial Notch
signaling along the gut tract, FGF10 signaling operates to
help maintain the epithelial progenitor niche. Further studies
309P. Nyeng et al. / Developmental Biology 303 (2007) 295–310should be aimed at defining how these signaling systems may
interact, as such knowledge is likely to be important in
understanding both the development of gastric cancer, as well
as programs of stomach regeneration, and how these processes
may be modulated.
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